Brief: Faron Pharmaceuticals Plans Rights Offering Of EUR 40 Mln

Faron Pharmaceuticals Oy

10/02/2026 07:19

Feb 10 (Reuters) - Faron Pharmaceuticals Oy FARN.L:

SAID ON MONDAY PLANS RIGHTS OFFERING OF ABOUT EUR 40 MLN TO STRENGTHEN ITS CAPITAL STRUCTURE AND TO DRIVE LEAD ASSET BEXMARILIMAB TO KEY MILESTONES

TO CONVENE EXTRAORDINARY GENERAL MEETING ON 2 MARCH 2026

PROPOSES COMPLETE RESPONSE AS APPROVAL ENDPOINT

Source text: nMFN5bGCQC

Further company coverage: FARN.L

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))